Skip to main content

Table 3 Adjusted1) associations of 10 cytokine polymorphisms with elevated serum levels of total IgE in the ECRHS-Basel Study.

From: Cytokine gene polymorphisms and atopic disease in two European cohorts. (ECRHS-Basel and SAPALDIA)

 

Elevated total IgE cases2)

Genotype

 

cases/controls 3)

Odds Ratio

95% Conficence Interval

P-value

IL4 (-589C>T)

CC

69/227

1

--

--

 

CT

25/81

1

0.57 – 1.65

0.91

 

TT

7/6

3.89

1.24 – 12.15

0.02

IL4R Q576R (A>G)

AA

67/194

1

--

--

 

AG

30/105

0.91

0.55 – 1.50

0.71

 

GG

4/9

1.31

0.38 – 4.51

0.67

IL6(-174G>C)

GG

34/98

1

--

--

 

GC

49/151

0.91

0.54 – 1.52

0.71

 

CC

18/62

0.80

0.41 – 1.56

0.52

IL10 (-1082G>A)

GG

35/112

1

--

--

 

GA

54/137

1.22

0.74 – 2.01

0.44

 

AA

12/64

0.55

0.27 – 1.16

0.12

IL10 (-819C>T)

CC

44/180

1

--

--

 

CT

48/112

1.81

1.12 – 2.92

0.02

 

TT

9/20

1.96

0.82 – 4.67

0.13

IL12p40(1188A>C)

AA

61/183

1

--

--

 

AC

39/112

1.03

0.64 – 1.66

0.89

 

CC

1/18

0.16

0.02 – 1.20

0.08

IL13 R130Q (A>G)

GG

68/206

1

--

--

 

GA

28/96

0.82

0.49 – 1.37

0.46

 

AA

5/9

2.14

0.67 – 6.78

0.19

IL18(-137G>C)

GG

43/163

1

--

--

 

GC

42/127

1.22

0.75 – 2.00

0.42

 

CC

16/24

2.51

1.21 – 5.20

0.01

TNF(-308G>A)

GG

66/220

1

--

--

 

GA

33/85

1.41

0.86 – 2.32

0.17

 

AA

2/7

1.18

0.23 – 5.98

0.84

CD14 (-159C>T)

CC

24/88

1

--

--

 

CT

55/140

1.44

0.83 – 2.52

0.19

 

TT

21/79

0.97

0.50 – 1.90

0.94

  1. 1) Adjusted for age and gender.
  2. 2) Elevated total IgE cases had serum IgE level >100 kU/L, measured by CAP system (Pharmacia Diagnostics). Controls had IgE = 100 kU/L.
  3. 3) Controls had IgE = 100 kU/L